carbapenems has been researched along with calca protein, human in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (calca protein, human) | Trials (calca protein, human) | Recent Studies (post-2010) (calca protein, human) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 2,318 | 197 | 1,082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, YY; Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Lim, CL; Lingegowda, PB; Ong, RW; Tang, SS; Teo, J | 1 |
1 other study(ies) available for carbapenems and calca protein, human
| Article | Year |
|---|---|
Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; Calcitonin; Calcitonin Gene-Related Peptide; Carbapenems; Drug Monitoring; Female; Humans; Male; Middle Aged; Neoplasms; Protein Precursors; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2012 |